BIOMAT Database Logo BIOMAT Database Logo

[Immunosuppressive therapy of intraocular inflammation. I. Basic principles, indications, contraindications, side-effects]. 1998

K S Manthey
Universitäts-Augenklinik Kiel.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009877 Endophthalmitis Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection. Ophthalmia,Infectious Endophthalmitis,Endophthalmitides,Endophthalmitides, Infectious,Endophthalmitis, Infectious,Infectious Endophthalmitides,Ophthalmias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

K S Manthey
[Ocalexic therapy. Principles--indications--contraindications].
January 1983, Le Chirurgien-dentiste de France,
K S Manthey
[Basic principles of progestin use (indications and contraindications)].
May 1979, Akusherstvo i ginekologiia,
K S Manthey
[INDICATIONS, CONTRAINDICATIONS AND SIDE-EFFECTS OF CORTISONE THERAPY IN PREGNANCY].
June 1963, Zentralblatt fur Gynakologie,
K S Manthey
[Prolonged immunosuppressive therapy in children. Indications and contraindications].
February 1973, Pediatria polska,
K S Manthey
[Thrombolytic therapy. I. Introduction and principles of therapy. Indications. Contraindications. Schematics of the treatment].
January 1969, Przeglad lekarski,
K S Manthey
Intraocular lenses: indications and contraindications.
January 1976, Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology,
K S Manthey
[Immunosuppressive therapy. A survey concerning rationale, risks, indications and contraindications].
October 1973, Ugeskrift for laeger,
K S Manthey
[Indications, collateral effects & contraindications of cortisonic therapy].
October 1958, L' Ospedale maggiore,
K S Manthey
[Side effects of immunosuppressive therapy].
June 1972, Monatsschrift fur Kinderheilkunde,
K S Manthey
[Strategies for the immunosuppressive therapy of intraocular inflammation].
April 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
Copied contents to your clipboard!